BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2842Drug Manufacturers - Specialty & Generic
$10.13 +$1.05 (+11.56%)
Pre-market · Oct 6, 5:10 am ET · After hours $10.11 -0.20%
Open$9.15
Prev close$9.08
Day range$9.12 – $10.24
Volume4.66M
Market cap$1.85B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-104.4x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 65.3x

Price / sales5.5x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average 3.6x

#3948 of 5147 stocks by PS (1 = cheapest)

P/E over five years

-499x410x1,319x2,228xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$8.54
Price vs. fair value+18.6%Trading above the estimate
Star rating★★☆☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -104.43 59.27 65.27 0% (cheaper than usual) –
PS 5.51 4.27 3.62 87% (pricier than usual) #3948 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★
Fair value estimate$8.54
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on XERS.

Leave a comment

Scroll to Top